Rewiring T-cell responses to soluble factors with chimeric antigen receptors (original) (raw)

• Sadelain, M., Rivière, I. & Riddell, S. Therapeutic T cell engineering. Nature 545, 423–431 (2017).
  CAS PubMed PubMed Central Google Scholar
• Chang, Z.L. & Chen, Y.Y. CARs: synthetic immunoreceptors for cancer therapy and Beyond. Trends Mol. Med. 23, 430–450 (2017).
  CAS PubMed PubMed Central Google Scholar
• Brown, C.E. et al. Regression of glioblastoma after chimeric antigen receptor T-cell therapy. N. Engl. J. Med. 375, 2561–2569 (2016).
  CAS PubMed PubMed Central Google Scholar
• Ali, A. et al. HIV-1-specific chimeric antigen receptors based on broadly neutralizing antibodies. J. Virol. 90, 6999–7006 (2016).
  CAS PubMed PubMed Central Google Scholar
• Ellebrecht, C.T. et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science 353, 179–184 (2016).
  CAS PubMed PubMed Central Google Scholar
• Hombach, A. et al. An anti-CD30 chimeric receptor that mediates CD3-ζ-independent T-cell activation against Hodgkin's lymphoma cells in the presence of soluble CD30. Cancer Res. 58, 1116–1119 (1998).
  CAS PubMed Google Scholar
• Lanitis, E. et al. Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor. Mol. Ther. 20, 633–643 (2012).
  CAS PubMed Google Scholar
• Nolan, K.F. et al. Bypassing immunization: optimized design of “designer T cells” against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA. Clin. Cancer Res. 5, 3928–3941 (1999).
  CAS PubMed Google Scholar
• Westwood, J.A. et al. The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum. J. Immunother. 32, 292–301 (2009).
  CAS PubMed Google Scholar
• Ma, Q., DeMarte, L., Wang, Y., Stanners, C.P. & Junghans, R.P. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins. Cancer Gene Ther. 11, 297–306 (2004).
  CAS PubMed Google Scholar
• Carpenter, R.O. et al. B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma. Clin. Cancer Res. 19, 2048–2060 (2013).
  CAS PubMed PubMed Central Google Scholar
• McGuinness, R.P. et al. Anti-tumor activity of human T cells expressing the CC49-zeta chimeric immune receptor. Hum. Gene Ther. 10, 165–173 (1999).
  CAS PubMed Google Scholar
• Chmielewski, M. et al. T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in mice. Gastroenterology 143, 1095–1107. e2 (2012).
  CAS PubMed Google Scholar
• Irving, B.A. & Weiss, A. The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 64, 891–901 (1991).
  CAS PubMed Google Scholar
• Letourneur, F. & Klausner, R.D. T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins. Proc. Natl. Acad. Sci. USA 88, 8905–8909 (1991).
  CAS PubMed PubMed Central Google Scholar
• Romeo, C. & Seed, B. Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides. Cell 64, 1037–1046 (1991).
  CAS PubMed Google Scholar
• Leibly, D.J. et al. A suite of engineered GFP molecules for oligomeric scaffolding. Structure 23, 1754–1768 (2015).
  CAS PubMed PubMed Central Google Scholar
• Kirchhofer, A. et al. Modulation of protein properties in living cells using nanobodies. Nat. Struct. Mol. Biol. 17, 133–138 (2010).
  CAS PubMed Google Scholar
• Tang, J.C.Y. et al. A nanobody-based system using fluorescent proteins as scaffolds for cell-specific gene manipulation. Cell 154, 928–939 (2013).
  CAS PubMed PubMed Central Google Scholar
• Mack, M., Riethmüller, G. & Kufer, P. A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. Proc. Natl. Acad. Sci. USA 92, 7021–7025 (1995).
  CAS PubMed PubMed Central Google Scholar
• Urbanska, K. et al. A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptor. Cancer Res. 72, 1844–1852 (2012).
  CAS PubMed PubMed Central Google Scholar
• Tamada, K. et al. Redirecting gene-modified T cells toward various cancer types using tagged antibodies. Clin. Cancer Res. 18, 6436–6445 (2012).
  CAS PubMed Google Scholar
• Rabinovich, G.A., Gabrilovich, D. & Sotomayor, E.M. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25, 267–296 (2007).
  CAS PubMed PubMed Central Google Scholar
• Flavell, R.A., Sanjabi, S., Wrzesinski, S.H. & Licona-Limón, P. The polarization of immune cells in the tumour environment by TGF-β. Nat. Rev. Immunol. 10, 554–567 (2010).
  CAS PubMed Google Scholar
• Koehler, H., Kofler, D., Hombach, A. & Abken, H. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack. Cancer Res. 67, 2265–2273 (2007).
  CAS PubMed Google Scholar
• Bunnell, S.C. et al. T cell receptor ligation induces the formation of dynamically regulated signaling assemblies. J. Cell Biol. 158, 1263–1275 (2002).
  CAS PubMed PubMed Central Google Scholar
• Campi, G., Varma, R. & Dustin, M.L. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J. Exp. Med. 202, 1031–1036 (2005).
  CAS PubMed PubMed Central Google Scholar
• Kim, S.T. et al. The alphabeta T cell receptor is an anisotropic mechanosensor. J. Biol. Chem. 284, 31028–31037 (2009).
  CAS PubMed PubMed Central Google Scholar
• Li, Y.-C. et al. Cutting edge: mechanical forces acting on T cells immobilized via the TCR complex can trigger TCR signaling. J. Immunol. 184, 5959–5963 (2010).
  CAS PubMed Google Scholar
• Liu, B., Chen, W., Evavold, B.D. & Zhu, C. Accumulation of dynamic catch bonds between TCR and agonist peptide-MHC triggers T cell signaling. Cell 157, 357–368 (2014).
  CAS PubMed PubMed Central Google Scholar
• Zhang, Y. et al. A flow cytometry method to quantitate internalized immunotoxins shows that taxol synergistically increases cellular immunotoxins uptake. Cancer Res. 70, 1082–1089 (2010).
  CAS PubMed PubMed Central Google Scholar
• Hargreaves, P.G. & Al-Shamkhani, A. Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30. Eur. J. Immunol. 32, 163–173 (2002).
  CAS PubMed Google Scholar
• Schwesinger, F. et al. Unbinding forces of single antibody-antigen complexes correlate with their thermal dissociation rates. Proc. Natl. Acad. Sci. USA 97, 9972–9977 (2000).
  CAS PubMed PubMed Central Google Scholar
• Hu, K.H. & Butte, M.J. T cell activation requires force generation. J. Cell Biol. 213, 535–542 (2016).
  CAS PubMed PubMed Central Google Scholar
• Zhang, H., Cordoba, S.-P., Dushek, O. & van der Merwe, P.A. Basic residues in the T-cell receptor ζ cytoplasmic domain mediate membrane association and modulate signaling. Proc. Natl. Acad. Sci. USA 108, 19323–19328 (2011).
  CAS PubMed PubMed Central Google Scholar
• Dobbins, J. et al. Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling. Sci. Signal. 9, ra75 (2016).
  PubMed PubMed Central Google Scholar
• van der Merwe, P.A. & Dushek, O. Mechanisms for T cell receptor triggering. Nat. Rev. Immunol. 11, 47–55 (2011).
  CAS PubMed Google Scholar
• Yokosuka, T. et al. Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C θ translocation. Immunity 29, 589–601 (2008).
  CAS PubMed PubMed Central Google Scholar
• Sadelain, M. Chimeric antigen receptors: driving immunology towards synthetic biology. Curr. Opin. Immunol. 41, 68–76 (2016).
  CAS PubMed PubMed Central Google Scholar
• Kalos, M. & June, C.H. Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology. Immunity 39, 49–60 (2013).
  CAS PubMed Google Scholar
• Matsuda, M., Koga, M., Nishida, E. & Ebisuya, M. Synthetic signal propagation through direct cell-cell interaction. Sci. Signal. 5, ra31 (2012).
  PubMed Google Scholar
• Gordon, W.R. et al. Mechanical allostery: evidence for a force requirement in the proteolytic activation of Notch. Dev. Cell 33, 729–736 (2015).
  CAS PubMed PubMed Central Google Scholar
• Morsut, L. et al. Engineering customized cell sensing and response behaviors using synthetic Notch receptors. Cell 164, 780–791 (2016).
  CAS PubMed PubMed Central Google Scholar
• Schwarz, K.A., Daringer, N.M., Dolberg, T.B. & Leonard, J.N. Rewiring human cellular input-output using modular extracellular sensors. Nat. Chem. Biol. 13, 202–209 (2017).
  CAS PubMed Google Scholar
• Hanash, S.M., Pitteri, S.J. & Faca, V.M. Mining the plasma proteome for cancer biomarkers. Nature 452, 571–579 (2008).
  CAS PubMed Google Scholar
• Hu, S., Loo, J.A. & Wong, D.T. Human body fluid proteome analysis. Proteomics 6, 6326–6353 (2006).
  CAS PubMed PubMed Central Google Scholar
• Fedorov, V.D., Themeli, M. & Sadelain, M. PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses. Sci. Transl. Med. 5, 215ra172 (2013).
  PubMed PubMed Central Google Scholar
• Kloss, C.C., Condomines, M., Cartellieri, M., Bachmann, M. & Sadelain, M. Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells. Nat. Biotechnol. 31, 71–75 (2013).
  CAS PubMed Google Scholar
• Grada, Z. et al. TanCAR: a novel bispecific chimeric antigen receptor for cancer immunotherapy. Mol. Ther. Nucleic Acids 2, e105 (2013).
  PubMed PubMed Central Google Scholar
• Zah, E., Lin, M.-Y., Silva-Benedict, A., Jensen, M.C. & Chen, Y.Y. T Cells expressing CD19/CD20 bispecific chimeric antigen receptors prevent antigen escape by malignant B cells. Cancer Immunol. Res. 4, 498–508 (2016).
  CAS PubMed PubMed Central Google Scholar
• Jonnalagadda, M. et al. Chimeric antigen receptors with mutated IgG4 Fc spacer avoid fc receptor binding and improve T cell persistence and antitumor efficacy. Mol. Ther. 23, 757–768 (2015).
  CAS PubMed PubMed Central Google Scholar
• Nguyen, P., Moisini, I. & Geiger, T.L. Identification of a murine CD28 dileucine motif that suppresses single-chain chimeric T-cell receptor expression and function. Blood 102, 4320–4325 (2003).
  CAS PubMed Google Scholar
• Moeller, M. et al. A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells. Cancer Gene Ther. 11, 371–379 (2004).
  CAS PubMed Google Scholar
• Zhao, Y. et al. A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity. J. Immunol. 183, 5563–5574 (2009).
  CAS PubMed Google Scholar
• Gressner, A.M., Weiskirchen, R., Breitkopf, K. & Dooley, S. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 7, d793–d807 (2002).
  CAS PubMed Google Scholar
• Junker, U. et al. Transforming growth factor beta 1 is significantly elevated in plasma of patients suffering from renal cell carcinoma. Cytokine 8, 794–798 (1996).
  CAS PubMed Google Scholar
• Yu, Q. & Stamenkovic, I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163–176 (2000).
  PubMed PubMed Central Google Scholar
• Zhang, Q. et al. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer. Cancer Res. 65, 1761–1769 (2005).
  CAS PubMed Google Scholar
• Foster, A.E. et al. Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor. J. Immunother. 31, 500–505 (2008).
  CAS PubMed PubMed Central Google Scholar
• El Hentati, F.-Z., Gruy, F., Iobagiu, C. & Lambert, C. Variability of CD3 membrane expression and T cell activation capacity. Cytometry B Clin. Cytom. 78, 105–114 (2010).
  PubMed Google Scholar